|
TWI491606B
(zh)
|
2009-07-13 |
2015-07-11 |
Gilead Sciences Inc |
調節細胞凋亡信號之激酶的抑制劑
|
|
EP2651417B1
(en)
|
2010-12-16 |
2016-11-30 |
Calchan Limited |
Ask1 inhibiting pyrrolopyrimidine derivatives
|
|
UY34573A
(es)
|
2012-01-27 |
2013-06-28 |
Gilead Sciences Inc |
Inhibidor de la quinasa que regula la señal de la apoptosis
|
|
WO2015081127A2
(en)
|
2013-11-26 |
2015-06-04 |
Gilead Sciences, Inc. |
Therapies for treating myeloproliferative disorders
|
|
US20160331754A1
(en)
|
2014-01-20 |
2016-11-17 |
Gilead Sciences, Inc. |
Therapies for treating cancers
|
|
WO2015187499A1
(en)
|
2014-06-03 |
2015-12-10 |
Gilead Sciences, Inc. |
Use of an ask1 inhibitor for the treatment of liver disease, optionally in combination with a loxl2 inhibitor
|
|
TW201618781A
(zh)
*
|
2014-08-13 |
2016-06-01 |
吉李德科學股份有限公司 |
治療肺高血壓之方法
|
|
SG11201701723XA
(en)
*
|
2014-09-24 |
2017-04-27 |
Gilead Sciences Inc |
Methods of treating liver disease
|
|
WO2016106384A1
(en)
*
|
2014-12-23 |
2016-06-30 |
Gilead Sciences, Inc. |
Processes for preparing ask1 inhibitors
|
|
MA41252A
(fr)
*
|
2014-12-23 |
2017-10-31 |
Gilead Sciences Inc |
Formes solides d'un inhibiteur d'ask 1
|
|
TW201639573A
(zh)
|
2015-02-03 |
2016-11-16 |
吉李德科學股份有限公司 |
有關治療癌症之合併治療
|
|
AU2016216673B2
(en)
|
2015-03-04 |
2017-02-02 |
Gilead Sciences, Inc. |
Toll like receptor modulator compounds
|
|
MX370984B
(es)
|
2015-07-06 |
2020-01-09 |
Gilead Sciences Inc |
Moduladores de cáncer de tiroides de osaka (cot) y métodos de uso de los mismos.
|
|
US20190054090A1
(en)
|
2015-10-01 |
2019-02-21 |
Gilead Sciences, Inc. |
Combination of a btk inhibitor and a checkpoint inhibitor for treating cancers
|
|
EP3355871A1
(en)
*
|
2015-10-02 |
2018-08-08 |
Gilead Sciences, Inc. |
Combinations of the btk inhibitor gs-4059 with inhibitors selected from a jak, ask1, brd and/or mmp9 inhibitor to treat cancer, allergic disorders, autoimmune diseases or inflammatory diseases
|
|
US10316049B2
(en)
|
2015-12-17 |
2019-06-11 |
Gilead Sciences, Inc. |
Tank-binding kinase inhibitor compounds
|
|
AU2017228371A1
(en)
|
2016-03-04 |
2018-09-13 |
Gilead Sciences, Inc. |
Compositions and combinations of autotaxin inhibitors
|
|
JP2019513737A
(ja)
|
2016-04-08 |
2019-05-30 |
ギリアード サイエンシーズ， インコーポレイテッド |
がん、炎症性疾患および自己免疫疾患を処置するための組成物および方法
|
|
WO2017215590A1
(en)
|
2016-06-13 |
2017-12-21 |
I-Mab |
Anti-pd-l1 antibodies and uses thereof
|
|
EP3493797A1
(en)
|
2016-08-04 |
2019-06-12 |
Gilead Sciences, Inc. |
Cobicistat for use in cancer treatments
|
|
EP3507288B1
(en)
|
2016-09-02 |
2020-08-26 |
Gilead Sciences, Inc. |
4,6-diamino-pyrido[3,2-d]pyrimidine derivaties as toll like receptor modulators
|
|
AU2017318601B2
(en)
|
2016-09-02 |
2020-09-03 |
Gilead Sciences, Inc. |
Toll like receptor modulator compounds
|
|
WO2018085069A1
(en)
|
2016-11-03 |
2018-05-11 |
Gilead Sciences, Inc. |
Combination of a bcl-2 inhibitor and a bromodomain inhibitor for treating cancer
|
|
KR20190083655A
(ko)
|
2016-11-11 |
2019-07-12 |
길리애드 사이언시즈, 인코포레이티드 |
간 질환을 치료하는 방법
|
|
WO2018097977A1
(en)
|
2016-11-22 |
2018-05-31 |
Gilead Sciences, Inc. |
Crystalline forms of a phosphate complex of a bet inhibitor
|
|
AR110252A1
(es)
|
2016-11-30 |
2019-03-13 |
Gilead Sciences Inc |
Compuestos heterocíclicos fusionados como inhibidores de la quinasa cam
|
|
CN109071448B
(zh)
*
|
2017-01-22 |
2020-03-17 |
福建广生堂药业股份有限公司 |
Ask1抑制剂及其制备方法和应用
|
|
PL3572412T3
(pl)
*
|
2017-01-22 |
2021-09-27 |
Fujian Cosunter Pharmaceutical Co., Ltd. |
Pochodna pirydyny jako inhibitor ask1 oraz sposób jej wytwarzania oraz zastosowanie
|
|
KR20200108915A
(ko)
|
2017-01-24 |
2020-09-21 |
아이-맵 바이오파마 유에스 리미티드 |
항-cd73 항체 및 이것의 사용
|
|
EP3585789A1
(en)
|
2017-02-24 |
2020-01-01 |
Gilead Sciences, Inc. |
Inhibitors of bruton's tyrosine kinase
|
|
CN110312720A
(zh)
|
2017-02-24 |
2019-10-08 |
吉利德科学公司 |
布鲁顿氏酪氨酸激酶的抑制剂
|
|
WO2018157277A1
(en)
|
2017-02-28 |
2018-09-07 |
Eli Lilly And Company |
Isoquinolin and naphthydrin compounds
|
|
CN111094250B
(zh)
*
|
2017-03-03 |
2022-11-04 |
江苏豪森药业集团有限公司 |
凋亡信号调节激酶抑制剂及其制备方法和应用
|
|
JOP20180017A1
(ar)
|
2017-03-14 |
2019-01-30 |
Gilead Sciences Inc |
مثبط كيناز منظم لإشارة تلاشي خلايا
|
|
WO2018183342A1
(en)
|
2017-03-28 |
2018-10-04 |
Gilead Sciences, Inc. |
Methods of treating liver disease
|
|
JP2020516627A
(ja)
|
2017-04-12 |
2020-06-11 |
ギリアード サイエンシーズ， インコーポレイテッド |
肝疾患を処置する方法
|
|
JOP20180040A1
(ar)
|
2017-04-20 |
2019-01-30 |
Gilead Sciences Inc |
مثبطات pd-1/pd-l1
|
|
JP7377718B2
(ja)
|
2017-05-12 |
2023-11-10 |
エナンタ ファーマシューティカルズ インコーポレイテッド |
アポトーシスシグナル調節キナーゼ１阻害剤およびその使用方法
|
|
US10450301B2
(en)
|
2017-05-25 |
2019-10-22 |
Enanta Pharmaceuticals, Inc. |
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
|
|
WO2018218044A2
(en)
*
|
2017-05-25 |
2018-11-29 |
Enanta Pharmaceuticals Inc |
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
|
|
WO2018218042A1
(en)
*
|
2017-05-25 |
2018-11-29 |
Enanta Pharmaceuticals, Inc. |
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
|
|
WO2018231851A1
(en)
|
2017-06-13 |
2018-12-20 |
Gilead Sciences, Inc. |
Methods of treating liver fibrosis
|
|
WO2019015559A1
(zh)
*
|
2017-07-18 |
2019-01-24 |
南京圣和药业股份有限公司 |
作为ask抑制剂的杂环化合物及其应用
|
|
WO2019046186A1
(en)
|
2017-08-28 |
2019-03-07 |
Enanta Pharmaceuticals, Inc. |
INHIBITORS OF KINASE 1 REGULATING THE APOPTOTIC SIGNAL CONTAINING TETRAZOLES AND METHODS OF USE THEREOF
|
|
CN109456308B
(zh)
*
|
2017-09-06 |
2022-11-29 |
南京圣和药业股份有限公司 |
作为ask抑制剂的杂环化合物及其应用
|
|
US10370352B2
(en)
|
2017-09-07 |
2019-08-06 |
Eli Lilly And Company |
Cyclobutyl-imidazolidinone compounds
|
|
WO2019047094A1
(en)
*
|
2017-09-07 |
2019-03-14 |
Eli Lilly And Company |
CYCLOBUTYL-IMIDAZOLIDINONE COMPOUNDS
|
|
WO2019047161A1
(en)
*
|
2017-09-08 |
2019-03-14 |
Eli Lilly And Company |
IMIDAZOLIDINE COMPOUNDS
|
|
CN111315380A
(zh)
|
2017-09-08 |
2020-06-19 |
弗朗塞拉美国制药有限责任公司 |
凋亡信号调节激酶抑制剂及其用途
|
|
CN111518080A
(zh)
*
|
2017-10-12 |
2020-08-11 |
深圳市塔吉瑞生物医药有限公司 |
一种1,2,4-三氮唑类化合物
|
|
CN107793400B
(zh)
*
|
2017-10-31 |
2020-01-31 |
武汉九州钰民医药科技有限公司 |
吡啶类化合物及其在制备治疗肝脏疾病的药物中的应用
|
|
EP3710599B1
(en)
|
2017-11-13 |
2024-07-17 |
Gilead Sciences, Inc. |
Method for staging liver fibrosis in nash patients
|
|
KR102492187B1
(ko)
|
2017-12-20 |
2023-01-27 |
인스티튜트 오브 오가닉 케미스트리 앤드 바이오케미스트리 에이에스 씨알 브이.브이.아이. |
Sting 어댑터 단백질을 활성화하는 포스포네이트 결합을 가진 3'3' 사이클릭 다이뉴클레오티드
|
|
CN111511754B
(zh)
|
2017-12-20 |
2023-09-12 |
捷克共和国有机化学与生物化学研究所 |
活化sting转接蛋白的具有膦酸酯键的2’3’环状二核苷酸
|
|
WO2019136025A1
(en)
|
2018-01-02 |
2019-07-11 |
Seal Rock Therapeutics, Inc. |
Ask1 inhibitor compounds and uses thereof
|
|
TWI796596B
(zh)
|
2018-02-13 |
2023-03-21 |
美商基利科學股份有限公司 |
Pd‐1/pd‐l1抑制劑
|
|
CN110294742B
(zh)
*
|
2018-03-21 |
2023-01-31 |
山东轩竹医药科技有限公司 |
并环类ask1抑制剂及其应用
|
|
TW202005654A
(zh)
|
2018-04-06 |
2020-02-01 |
捷克科學院有機化學與生物化學研究所 |
２，２，─環二核苷酸
|
|
TWI818007B
(zh)
|
2018-04-06 |
2023-10-11 |
捷克科學院有機化學與生物化學研究所 |
2'3'-環二核苷酸
|
|
TWI833744B
(zh)
|
2018-04-06 |
2024-03-01 |
捷克科學院有機化學與生物化學研究所 |
3'3'-環二核苷酸
|
|
US10919911B2
(en)
|
2018-04-12 |
2021-02-16 |
Terns, Inc. |
Tricyclic ASK1 inhibitors
|
|
KR102591947B1
(ko)
|
2018-04-19 |
2023-10-25 |
길리애드 사이언시즈, 인코포레이티드 |
Pd-1/pd-l1 억제제
|
|
CN110407806B
(zh)
*
|
2018-04-28 |
2021-08-17 |
深圳微芯生物科技股份有限公司 |
甲酰胺类化合物、其制备方法及其应用
|
|
AU2019262016B2
(en)
|
2018-05-02 |
2024-07-11 |
Enanta Pharmaceuticals, Inc. |
Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
|
|
WO2019213239A1
(en)
|
2018-05-02 |
2019-11-07 |
Enanta Pharmaceuticals Inc. |
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
|
|
US20190359645A1
(en)
|
2018-05-03 |
2019-11-28 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2'3'-cyclic dinucleotides comprising carbocyclic nucleotide
|
|
JP2021523151A
(ja)
|
2018-05-11 |
2021-09-02 |
ホスホレックス、インコーポレイテッド |
負の表面電荷を有するマイクロ粒子及びナノ粒子
|
|
EP4029868A1
(en)
|
2018-05-14 |
2022-07-20 |
Gilead Sciences, Inc. |
Mcl-1 inhibitors
|
|
WO2020006429A1
(en)
*
|
2018-06-28 |
2020-01-02 |
Hepatikos Therapeutics, Llc |
Ask1 isoindolin-1-one inhibitors and methods of use thereof
|
|
MX2021000100A
(es)
|
2018-07-13 |
2021-03-25 |
Gilead Sciences Inc |
Inhibidores de muerte programada-1 (pd-1)/ ligando de muerte programada 1 (pd-l1).
|
|
WO2020015721A1
(zh)
*
|
2018-07-20 |
2020-01-23 |
福建广生堂药业股份有限公司 |
作为ask1抑制剂的晶型及其制备方法和应用
|
|
US10968199B2
(en)
|
2018-08-22 |
2021-04-06 |
Enanta Pharmaceuticals, Inc. |
Cycloalkyl-containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
|
|
EP3860717A1
(en)
|
2018-10-03 |
2021-08-11 |
Gilead Sciences, Inc. |
Imidozopyrimidine derivatives
|
|
KR102298546B1
(ko)
|
2018-10-18 |
2021-09-08 |
에이치케이이노엔 주식회사 |
신규한 n-(이소프로필-트리아졸릴)피리디닐)-헤테로아릴-카르복사미드 유도체 및 이의 용도
|
|
JP7158577B2
(ja)
|
2018-10-24 |
2022-10-21 |
ギリアード サイエンシーズ， インコーポレイテッド |
Ｐｄ－１／ｐｄ－ｌ１阻害剤
|
|
KR102658602B1
(ko)
|
2018-10-31 |
2024-04-19 |
길리애드 사이언시즈, 인코포레이티드 |
Hpk1 억제 활성을 갖는 치환된 6-아자벤즈이미다졸 화합물
|
|
HRP20240541T1
(hr)
|
2018-10-31 |
2024-07-05 |
Gilead Sciences, Inc. |
Supstituirani spojevi 6-azabenzimidazola kao inhibitori hpk1
|
|
CN111170995A
(zh)
*
|
2018-11-09 |
2020-05-19 |
山东轩竹医药科技有限公司 |
Ask1抑制剂及其应用
|
|
WO2020106707A1
(en)
|
2018-11-19 |
2020-05-28 |
Enanta Pharmaceuticals, Inc. |
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
|
|
CN109608441A
(zh)
*
|
2018-12-26 |
2019-04-12 |
都创(上海)医药科技有限公司 |
一种ask1抑制剂的合成工艺
|
|
FI3911647T3
(fi)
|
2019-01-15 |
2024-03-01 |
Gilead Sciences Inc |
Isoksatsoliyhdiste fxr-agonistina ja sitä käsittäviä lääkekoostumuksia
|
|
CN109813915A
(zh)
*
|
2019-02-15 |
2019-05-28 |
浠思（上海）生物技术有限公司 |
利用htrf一步法筛选激酶抑制剂的方法
|
|
US11524005B2
(en)
|
2019-02-19 |
2022-12-13 |
Gilead Sciences, Inc. |
Solid forms of FXR agonists
|
|
AU2020231115B2
(en)
|
2019-03-07 |
2025-02-20 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
3'3'-cyclic dinucleotides and prodrugs thereof
|
|
WO2020178768A1
(en)
|
2019-03-07 |
2020-09-10 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
3'3'-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide as sting modulator
|
|
DK3934757T3
(da)
|
2019-03-07 |
2023-04-17 |
Inst Of Organic Chemistry And Biochemistry Ascr V V I |
2'3'-cykliske dinukleotider og prodrugs deraf
|
|
KR20210136081A
(ko)
|
2019-03-11 |
2021-11-16 |
길리애드 사이언시즈, 인코포레이티드 |
화합물의 제제 및 그의 용도
|
|
US11466033B2
(en)
|
2019-03-25 |
2022-10-11 |
Enanta Pharmaceuticals, Inc. |
Substituted pyridines as apoptosis signal-regulating kinase 1 inhibitors
|
|
TW202212339A
(zh)
|
2019-04-17 |
2022-04-01 |
美商基利科學股份有限公司 |
類鐸受體調節劑之固體形式
|
|
TWI751516B
(zh)
|
2019-04-17 |
2022-01-01 |
美商基利科學股份有限公司 |
類鐸受體調節劑之固體形式
|
|
US11453681B2
(en)
|
2019-05-23 |
2022-09-27 |
Gilead Sciences, Inc. |
Substituted eneoxindoles and uses thereof
|
|
TWI770527B
(zh)
|
2019-06-14 |
2022-07-11 |
美商基利科學股份有限公司 |
Cot 調節劑及其使用方法
|
|
WO2020255038A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and pyridopyrimidine derivatives
|
|
KR102776925B1
(ko)
|
2019-06-25 |
2025-03-11 |
길리애드 사이언시즈, 인코포레이티드 |
Flt3l-fc 융합 단백질 및 사용 방법
|
|
US20220332700A1
(en)
*
|
2019-06-26 |
2022-10-20 |
Mankind Pharma Ltd |
Novel apoptosis signal-regulating kinase 1 inhibitors
|
|
AR119594A1
(es)
|
2019-08-09 |
2021-12-29 |
Gilead Sciences Inc |
Derivados de tienopirimidina como inhibidores acc y usos de los mismos
|
|
EP4045083B1
(en)
|
2019-10-18 |
2024-01-10 |
Forty Seven, Inc. |
Combination therapies for treating myelodysplastic syndromes and acute myeloid leukemia
|
|
CA3153636A1
(en)
|
2019-10-31 |
2021-05-06 |
Forty Seven, Inc. |
Anti-cd47 and anti-cd20 based treatment of blood cancer
|
|
TWI778443B
(zh)
|
2019-11-12 |
2022-09-21 |
美商基利科學股份有限公司 |
Mcl1抑制劑
|
|
US11548871B2
(en)
|
2019-11-15 |
2023-01-10 |
Gilead Sciences, Inc. |
Triazole carbamate pyridyl sulfonamides as LPA receptor antagonists and uses thereof
|
|
CN111018831B
(zh)
*
|
2019-11-21 |
2022-05-31 |
中国药科大学 |
细胞凋亡信号调节激酶抑制剂及其应用
|
|
US20230105984A1
(en)
|
2019-12-23 |
2023-04-06 |
Svetlana Marukian |
Compositions and methods for the treatment of liver diseases and disorders
|
|
PH12022551441A1
(en)
|
2019-12-24 |
2023-11-20 |
Carna Biosciences Inc |
Diacylglycerol kinase modulating compounds
|
|
MX2022009947A
(es)
|
2020-02-14 |
2022-11-07 |
Jounce Therapeutics Inc |
Anticuerpos y proteinas de fusion que se unen a ccr8 y usos de estos.
|
|
EP4126231A1
(en)
|
2020-03-30 |
2023-02-08 |
Gilead Sciences, Inc. |
Solid forms of (s)-6-(((1-(bicyclo[1.1.1]pentan-1-yl)-1h-1,2,3-triazol-4-yl)2-methyl-1-oxo-1,2- dihydroisoquinolin-5-yl)methyl)))amino)8-chloro-(neopentylamino)quinoline-3-carb onitrile a cot inhibitor compound
|
|
WO2021202688A1
(en)
|
2020-04-02 |
2021-10-07 |
Gilead Sciences, Inc. |
Process for preparing a cot inhibitor compound
|
|
EP4143194A1
(en)
|
2020-05-01 |
2023-03-08 |
Gilead Sciences, Inc. |
Cd73 inhibiting 2,4-dioxopyrimidine compounds
|
|
EP4161936A1
(en)
|
2020-06-03 |
2023-04-12 |
Gilead Sciences, Inc. |
Lpa receptor antagonists and uses thereof
|
|
CN113831323B
(zh)
*
|
2020-06-24 |
2025-08-29 |
武汉人福创新药物研发中心有限公司 |
芳杂环酰胺类化合物及其用途
|
|
CN111808079A
(zh)
*
|
2020-08-05 |
2020-10-23 |
中国药科大学 |
吲哚类ask1小分子抑制剂及其制备方法和应用
|
|
CN114470217B
(zh)
*
|
2020-11-24 |
2023-06-20 |
深圳微芯生物科技股份有限公司 |
预防和治疗代谢异常或炎症引起的组织损伤的药物组合物
|
|
US12091404B2
(en)
|
2021-03-11 |
2024-09-17 |
Gilead Sciences, Inc. |
GLP-1R modulating compounds
|
|
CN117120429A
(zh)
|
2021-03-29 |
2023-11-24 |
吉利德科学公司 |
Khk抑制剂
|
|
TW202302145A
(zh)
|
2021-04-14 |
2023-01-16 |
美商基利科學股份有限公司 |
ＣＤ４７／ＳＩＲＰα結合及ＮＥＤＤ８活化酶Ｅ１調節次單元之共抑制以用於治療癌症
|
|
CN114246866B
(zh)
*
|
2021-04-28 |
2023-09-12 |
深圳微芯生物科技股份有限公司 |
用于治疗慢性肾病的药物及其用途
|
|
TWI818538B
(zh)
|
2021-05-11 |
2023-10-11 |
美商基利科學股份有限公司 |
Ｌｐａ受體拮抗劑及其用途
|
|
US12503454B2
(en)
|
2021-05-13 |
2025-12-23 |
Gilead Sciences, Inc. |
LPA receptor antagonists and uses thereof
|
|
TW202313094A
(zh)
|
2021-05-18 |
2023-04-01 |
美商基利科學股份有限公司 |
使用ＦＬＴ３Ｌ—Ｆｃ融合蛋白之方法
|
|
TW202345826A
(zh)
|
2021-06-04 |
2023-12-01 |
美商基利科學股份有限公司 |
治療nash之方法
|
|
TW202311256A
(zh)
|
2021-06-18 |
2023-03-16 |
美商基利科學股份有限公司 |
用於治療ｆｘｒ誘發之搔癢之ｉｌ－３１調節劑
|
|
CN117480155A
(zh)
|
2021-06-23 |
2024-01-30 |
吉利德科学公司 |
二酰基甘油激酶调节化合物
|
|
US11999733B2
(en)
|
2021-06-23 |
2024-06-04 |
Gilead Sciences, Inc. |
Diacylglycerol kinase modulating compounds
|
|
CN117355531A
(zh)
|
2021-06-23 |
2024-01-05 |
吉利德科学公司 |
二酰基甘油激酶调节化合物
|
|
KR20240005901A
(ko)
|
2021-06-23 |
2024-01-12 |
길리애드 사이언시즈, 인코포레이티드 |
디아실글리세롤 키나제 조절 화합물
|
|
US20230183216A1
(en)
|
2021-10-28 |
2023-06-15 |
Gilead Sciences, Inc. |
Pyridizin-3(2h)-one derivatives
|
|
CA3235986A1
(en)
|
2021-10-29 |
2023-05-04 |
Gilead Science, Inc. |
Cd73 compounds
|
|
US11939318B2
(en)
|
2021-12-08 |
2024-03-26 |
Gilead Sciences, Inc. |
LPA receptor antagonists and uses thereof
|
|
US20230203202A1
(en)
|
2021-12-08 |
2023-06-29 |
Dragonfly Therapeutics, Inc. |
Proteins binding nkg2d, cd16 and 5t4
|
|
US20230220106A1
(en)
|
2021-12-08 |
2023-07-13 |
Dragonfly Therapeutics, Inc. |
Antibodies targeting 5t4 and uses thereof
|
|
JP2024546851A
(ja)
|
2021-12-22 |
2024-12-26 |
ギリアード サイエンシーズ， インコーポレイテッド |
Ｉｋａｒｏｓジンクフィンガーファミリー分解剤及びその使用
|
|
AU2022417491A1
(en)
|
2021-12-22 |
2024-05-23 |
Gilead Sciences, Inc. |
Ikaros zinc finger family degraders and uses thereof
|
|
TW202340168A
(zh)
|
2022-01-28 |
2023-10-16 |
美商基利科學股份有限公司 |
Ｐａｒｐ７抑制劑
|
|
CR20240386A
(es)
|
2022-03-17 |
2024-10-24 |
Gilead Sciences Inc |
Degradadores de dedos de zinc de la familia ikaros y usos de estos
|
|
AU2023240346A1
(en)
|
2022-03-24 |
2024-09-19 |
Gilead Sciences, Inc. |
Combination therapy for treating trop-2 expressing cancers
|
|
TWI876305B
(zh)
|
2022-04-05 |
2025-03-11 |
美商基利科學股份有限公司 |
用於治療結腸直腸癌之組合療法
|
|
AU2023256670A1
(en)
|
2022-04-21 |
2024-10-17 |
Gilead Sciences, Inc. |
Kras g12d modulating compounds
|
|
CA3260083A1
(en)
|
2022-07-01 |
2024-01-04 |
Gilead Sciences, Inc. |
CD73 COMPOUNDS
|
|
US20240091351A1
(en)
|
2022-09-21 |
2024-03-21 |
Gilead Sciences, Inc. |
FOCAL IONIZING RADIATION AND CD47/SIRPa DISRUPTION ANTICANCER COMBINATION THERAPY
|
|
AU2023409398A1
(en)
|
2022-12-22 |
2025-06-05 |
Gilead Sciences, Inc. |
Prmt5 inhibitors and uses thereof
|
|
CN115844887B
(zh)
*
|
2022-12-28 |
2023-09-08 |
中国人民解放军空军军医大学 |
Selonsertib在制备治疗癌症的药物中的用途
|
|
AU2024252725A1
(en)
|
2023-04-11 |
2025-11-06 |
Gilead Sciences, Inc. |
Kras modulating compounds
|
|
AU2024259556A1
(en)
|
2023-04-21 |
2025-10-23 |
Gilead Sciences, Inc. |
Prmt5 inhibitors and uses thereof
|
|
WO2024236595A1
(en)
*
|
2023-05-18 |
2024-11-21 |
Council Of Scientific And Industrial Research |
Protacs for ask1 protein degradation: preparation and use thereof
|
|
WO2025006720A1
(en)
|
2023-06-30 |
2025-01-02 |
Gilead Sciences, Inc. |
Kras modulating compounds
|
|
WO2025024663A1
(en)
|
2023-07-26 |
2025-01-30 |
Gilead Sciences, Inc. |
Parp7 inhibitors
|
|
TW202519517A
(zh)
|
2023-07-26 |
2025-05-16 |
美商基利科學股份有限公司 |
Ｐａｒｐ７抑制劑
|
|
WO2025054530A1
(en)
|
2023-09-08 |
2025-03-13 |
Gilead Sciences, Inc. |
Pyrimidine-containing polycyclic derivatives as kras g12d modulating compounds
|
|
US20250101042A1
(en)
|
2023-09-08 |
2025-03-27 |
Gilead Sciences, Inc. |
Kras g12d modulating compounds
|
|
US20250154172A1
(en)
|
2023-11-03 |
2025-05-15 |
Gilead Sciences, Inc. |
Prmt5 inhibitors and uses thereof
|
|
WO2025137640A1
(en)
|
2023-12-22 |
2025-06-26 |
Gilead Sciences, Inc. |
Azaspiro wrn inhibitors
|
|
WO2025245003A1
(en)
|
2024-05-21 |
2025-11-27 |
Gilead Sciences, Inc. |
Prmt5 inhibitors and uses thereof
|